Wolverine Trading
ELDN icon

Wolverine Trading’s Eledon Pharmaceuticals ELDN Stock Holding History

Wolverine Trading’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$179K Buy
+70,600
New +$206K ﹤0.01% 4979
2025
Q2 		– Sell
-21,000
Closed -$70.3K – 4966
2025
Q1 		$70.3K Buy
+21,000
New +$86.4K ﹤0.01% 4325

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wolverine Trading's ELDN Position: Q3 2025 in Review

Wolverine Trading opened a new position in Eledon Pharmaceuticals (ELDN) in Q3 2025: 59,574 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #5058 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in ELDN as recently as Q1 2025.

Wolverine Trading first reported a position in ELDN in Q1 2025 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold ELDN as of Q3 2025.

  • Wolverine Trading held 59,574 shares of Eledon Pharmaceuticals worth $151K as of Q3 2025.
  • Eledon Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
  • Eledon Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5058 holding.
  • Wolverine Trading first reported a position in Eledon Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 83 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.